Skip to main content

Table 2 Patient characteristics 2015–2016

From: Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016

 

2015

2016

N (%)

N (%)

Total number of isolates

2134

2660

Gender

 Male

1736 (81.8)Ç‚Ç‚

2256 (85.1)^ Ç‚Ç‚

 Female

385 (18.2)Ç‚Ç‚

395 (14.9) Ç‚Ç‚

 Unknown

13

9

Age (years)

 < 25

617 (29.5)

720 (27.5)

 ≥25

1476 (70.5)

1902 (72.5)

 Unknown

41

38

Sexual orientation & gender

 Females

385 (26.4)Ç‚Ç‚

395 (22.9) Ç‚Ç‚

 Heterosexual males

419 (28.7)Ç‚Ç‚

632 (36.7) Ç‚Ç‚

 Men who have sex with men

657 (45.0)

696 (40.4)^ Ç‚Ç‚

 Unknown

673

937

Site of infection

 Genital

1517 (72.9)Ç‚Ç‚

1943 (75.5)

 Pharyngeal

180 (8.7)

165 (6.4) Ç‚Ç‚

 Anorectal

280 (13.5)Ç‚Ç‚

366 (14.2)

 Other

103 (5.0)Ç‚Ç‚

100 (3.9)

 Unknown

54

86

Previous gonorrhoea

 Yes

157 (17.5)

171 (17.2)

 No

739 (82.5)

824 (82.8)

 Unknown

1238

1665

Concurrent STI

 Concurrent chlamydia infection

153†† (19.0)

203 (23.9)˜ ǂǂ

 Concurrent other STI (not HIV)

48†† (6.0)

53 (6.2) ††

 No concurrent STI

605 (75.1)

593 (69.9) Ç‚Ç‚

 Unknown

1328

1811

HIV status

 Positive

132 (15.3)Ç‚Ç‚

156 (15.9)

 Negative

733 (84.7)Ç‚Ç‚

823 (84.1)

 Unknown

1269

1681

  1. Percentages calculated from known values
  2. ††Includes four individuals with two concurrent STIs
  3. ǂǂSignificant difference compared to previous year (p < 0.05)
  4. ^Includes one individual of unknown gender, but with mode of transmission reported as MSM
  5. ˜ Includes nine individuals with chlamydia and an additionally diagnosed STI